
Detects exposure to rickettsia bacteria, which are most often transmitted by tick bites and cause fever and rash.
Description of the blood test:
The Rickettsia antibody test is a specialized laboratory study used to detect an infection caused by bacteria of the genus Rickettsia. These pathogens are typically transmitted to humans through the bites of ticks, fleas, or lice and are responsible for diseases such as Rocky Mountain spotted fever and various forms of Typhus. The test identifies the body’s immune response (antibodies) to these intracellular bacteria. Since rickettsial diseases often present with non-specific symptoms like fever and rash, this serological marker is a vital tool for confirming the diagnosis and ensuring the patient receives the specific antibiotic therapy required for these unique organisms.
What does the analysis represent?
Recommendations for the test (General)
What can affect the results?
When to take the test?
How to interpret the results?
The interpretation of data is the exclusive responsibility of an infectious disease specialist or a neurologist. The presence or level of Rickettsia antibodies is a clinical indicator of immune exposure and is not a standalone diagnosis. The physician analyzes the results in the context of the patient’s travel history, insect exposure, and clinical signs. Only an expert can determine if the identified titers represent an active acute infection or a past exposure and decide on the necessary course of targeted treatment.
Possible further investigations
When does the next step make sense?
A positive result, especially a rising titer, is a signal for immediate medical management. Because rickettsial infections can progress rapidly and affect the vascular and nervous systems, the next step—a consultation with a specialist—is crucial to confirm the diagnosis and ensure a full recovery through appropriate therapy.
👉 If necessary, you can discuss the test results with our specialized — neurologist (Doctors – TAMC).